These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 20230883)

  • 1. Ternary nanoparticles of anionic lipid nanoparticles/protamine/DNA for gene delivery.
    Yuan H; Zhang W; Du YZ; Hu FQ
    Int J Pharm; 2010 Jun; 392(1-2):224-31. PubMed ID: 20230883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. pDNA condensation capacity and in vitro gene delivery properties of cationic solid lipid nanoparticles.
    Vighi E; Ruozi B; Montanari M; Battini R; Leo E
    Int J Pharm; 2010 Apr; 389(1-2):254-61. PubMed ID: 20100555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ternary nanoparticles composed of cationic solid lipid nanoparticles, protamine, and DNA for gene delivery.
    He SN; Li YL; Yan JJ; Zhang W; Du YZ; Yu HY; Hu FQ; Yuan H
    Int J Nanomedicine; 2013; 8():2859-69. PubMed ID: 23990715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modified nanoprecipitation method to fabricate DNA-loaded PLGA nanoparticles.
    Niu X; Zou W; Liu C; Zhang N; Fu C
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1375-83. PubMed ID: 19832638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding the mechanism of protamine in solid lipid nanoparticle-based lipofection: the importance of the entry pathway.
    Delgado D; del Pozo-Rodríguez A; Solinís MÁ; Rodríguez-Gascón A
    Eur J Pharm Biopharm; 2011 Nov; 79(3):495-502. PubMed ID: 21726641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and characterization of modified lipid nanoparticles for doxorubicin controlled release.
    Ying XY; Du YZ; Chen WW; Yuan H; Hu FQ
    Pharmazie; 2008 Dec; 63(12):878-82. PubMed ID: 19177903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A smart nanoassembly consisting of acid-labile vinyl ether PEG-DOPE and protamine for gene delivery: preparation and in vitro transfection.
    Xu Z; Gu W; Chen L; Gao Y; Zhang Z; Li Y
    Biomacromolecules; 2008 Nov; 9(11):3119-26. PubMed ID: 18834174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low molecular weight protamine as an efficient and nontoxic gene carrier: in vitro study.
    Park YJ; Liang JF; Ko KS; Kim SW; Yang VC
    J Gene Med; 2003 Aug; 5(8):700-11. PubMed ID: 12898639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anionic solid lipid nanoparticles supported on protamine/DNA complexes.
    Ye J; Wang A; Liu C; Chen Z; Zhang N
    Nanotechnology; 2008 Jul; 19(28):285708. PubMed ID: 21828742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear localization of cationic solid lipid nanoparticles containing Protamine as transfection promoter.
    Vighi E; Montanari M; Ruozi B; Tosi G; Magli A; Leo E
    Eur J Pharm Biopharm; 2010 Nov; 76(3):384-93. PubMed ID: 20691262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and characterization of a new plasmid delivery system based on chitosan-sodium deoxycholate nanoparticles.
    Cadete A; Figueiredo L; Lopes R; Calado CC; Almeida AJ; Gonçalves LM
    Eur J Pharm Sci; 2012 Mar; 45(4):451-8. PubMed ID: 21986445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High gene delivery in tumor by intratumoral injection of tetraarginine-PEG lipid-coated protamine/DNA.
    Fujita T; Furuhata M; Hattori Y; Kawakami H; Toma K; Maitani Y
    J Control Release; 2008 Jul; 129(2):124-7. PubMed ID: 18513820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oligonucleotide-protamine-albumin nanoparticles: Protamine sulfate causes drastic size reduction.
    Mayer G; Vogel V; Weyermann J; Lochmann D; van den Broek JA; Tziatzios C; Haase W; Wouters D; Schubert US; Zimmer A; Kreuter J; Schubert D
    J Control Release; 2005 Aug; 106(1-2):181-7. PubMed ID: 16002173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospects of anionic nanolipoplexes in nanotherapy: transmission electron microscopy and light scattering studies.
    Mozafari MR; Reed CJ; Rostron C
    Micron; 2007; 38(8):787-95. PubMed ID: 17681472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protamine sulfate-calcium carbonate-plasmid DNA ternary nanoparticles for efficient gene delivery.
    Wang CQ; Wu JL; Zhuo RX; Cheng SX
    Mol Biosyst; 2014 Mar; 10(3):672-8. PubMed ID: 24442276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histidylated cationic polyorganophosphazene/DNA self-assembled nanoparticles for gene delivery.
    Yang Y; Xu Z; Chen S; Gao Y; Gu W; Chen L; Pei Y; Li Y
    Int J Pharm; 2008 Apr; 353(1-2):277-82. PubMed ID: 18180117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and cytotoxicity of 2-methoxyestradiol-loaded solid lipid nanoparticles.
    Guo X; Xing Y; Mei Q; Zhang H; Zhang Z; Cui F
    Anticancer Drugs; 2012 Feb; 23(2):185-90. PubMed ID: 22027535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of protamine amount in the transfection performance of cationic SLN designed as a gene nanocarrier.
    Vighi E; Montanari M; Ruozi B; Iannuccelli V; Leo E
    Drug Deliv; 2012 Jan; 19(1):1-10. PubMed ID: 22070724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galactosylated ternary DNA/polyphosphoramidate nanoparticles mediate high gene transfection efficiency in hepatocytes.
    Zhang XQ; Wang XL; Zhang PC; Liu ZL; Zhuo RX; Mao HQ; Leong KW
    J Control Release; 2005 Feb; 102(3):749-63. PubMed ID: 15681095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folate-PEG modified poly(2-(2-aminoethoxy)ethoxy)phosphazene/DNA nanoparticles for gene delivery: synthesis, preparation and in vitro transfection efficiency.
    Zhang P; Zhang Z; Yang Y; Li Y
    Int J Pharm; 2010 Jun; 392(1-2):241-8. PubMed ID: 20298769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.